Circulatory monitoring systems and methods
AssigneeThe Invention Science Fund I, LLC
InventorsBran Ferren, Jeffrey John Hagen, Roderick A. Hyde, Muriel Y. Ishikawa, Eric C. Leuthardt, Dennis J. Rivet, Lowell L. Wood, Jr., Victoria Y. H. Wood
Life of this patent
Estimating the term…
Abstract
Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. Some involve implementing or deploying therapeutic administration systems, for example, for obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement.
Claims16
A therapeutic administration system comprising:
- a first dispenser operable for dispensing at least a clot-reducing agent;
- circuitry for obtaining a flow-change-indicative measurement;
- circuitry for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement;
- a second dispenser operable for targeting an implant site;
- and
- a wireless-communication device operable for communicating a selection of at least one of the first dispenser or the second dispenser.
A therapeutic administration system comprising:
- a first dispenser operable for dispensing at least a lytic material;
- circuitry for signaling a decision whether or not to administer one or more clot-reducing agents at least partly based on a flow-change-indicative measurement, the lytic material being one of the one or more clot-reducing agents;
- a second dispenser operable for targeting an implant site;
- and
- a wireless-communication device operable for communicating a selection of at least one of the first dispenser or the second dispenser.
A therapeutic administration system comprising:
- a first dispenser operable for dispensing at least a lytic material;
- circuitry for obtaining a flow-change-indicative measurement;
- circuitry for signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement, including:
- (1) one or more of a flow-force-responsive element, an optical sensor, or an auditory sensor;
- (2) circuitry for deciding upon at least one of the one or more clot-reducing agents in response to obtaining an anomalous value as the flow-change-indicative measurement;
- (3) circuitry for causing one or more dispensations in response to an apparent problem in the flow-change-indicative measurement;
- (4) circuitry for signaling an anticoagulant in response to an apparent flow degradation, the anticoagulant being one of the one or more clot-reducing agents;
- a second dispenser operable for targeting an implant site;
- and
- a wireless-communication device operable for communicating a selection of at least one of the first dispenser or the second dispenser.
Dependencies are inferred from the claim text.